Home / Recalls / Lannett Company, Inc. / D-0309-2020

D-0309-2020 Class II Terminated

Recalled by Lannett Company, Inc. — Philadelphia, PA

Recall Details

Product Type
Drugs
Report Date
November 20, 2019
Initiation Date
October 28, 2019
Termination Date
April 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
683,149 bottles

Product Description

Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett Company, Inc. Philadelphia, PA 19154 NDC 54838-550-80

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Distribution Pattern

Nationwide

Code Information

1503A 10/2019 1504A 10/2019 1505A 10/2019 1523A 10/2019 1524A 10/2019 1525A 11/2019 1561A 12/2019 1562A 12/2019 1563A 12/2019 1589A 12/2019 1590A 12/2019 1591A 12/2019 1614A 01/2020 1615A 01/2020 1617A 01/2020 1644A 02/2020 1775A 06/2020 1646A 02/2020 1647A 02/2020 1668A 03/2020 1669A 03/2020 1670A 03/2020 1708A 03/2020 1709A 04/2020 1710A 04/2020 1729A 04/2020 1730A 04/2020 1731A 04/2020 1757A 05/2020 1758A 05/2020 1759A 05/2020 1773A 06/2020 1774A 06/2020 1989A 12/2020 1794A 06/2020 1795A 06/2020 1796A 06/2020 1817A 06/2020 1818A 07/2020 1819A 07/2020 1840A 08/2020 1840B 08/2020 1841A 08/2020 1842A 08/2020 1863A 08/2020 1864A 09/2020 1865A 09/2020 1899A 10/2020 1900A 10/2020 1901A 10/2020 1910A 10/2020 1911A 10/2020 1912A 10/2020 1918A 10/2020 1919A 10/2020 1920A 10/2020 1925A 10/2020 1926A 10/2020 1927A 10/2020 1977A 12/2020 1978A 12/2020 1979A 12/2020 1990A 12/2020 1991A 12/2020 1998A 01/2021 1999A 01/2021 2000A 01/2021 2019A 01/2021 2020A 01/2021 2065A 03/2021 2066A 03/2021 2067A 03/2021 2071A 03/2021 2072A 03/2021 2073A 03/2021 2076A 03/2021 2077A 03/2021 2078A 03/2021 2126A 05/2021 2127A 05/2021 2128A 05/2021 2164A 06/2021 2165A 06/2021 2166A 06/2021 2179A 06/2021 2180A 07/2021 2181A 07/2021 2214A 08/2021 2215A 08/2021 2216A 08/2021

Other recalls by Lannett Company, Inc.

  • D-0096-2026 Class II — Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, (October 10, 2025)
  • D-0642-2025 Class II — Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate a (August 19, 2025)
  • D-0599-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distrib (August 11, 2025)
  • D-0112-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, D (October 25, 2024)
  • D-0161-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 (November 9, 2022)
  • D-0160-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 (November 9, 2022)
  • D-0558-2022 Class II — Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and (February 9, 2022)
  • D-1508-2020 Class II — Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett C (August 10, 2020)
  • D-0630-2020 Class I — Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Dist (December 6, 2019)
  • D-0996-2019 Class III — Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, D (February 21, 2019)